Toyota followed in Uber’s footsteps Tuesday, pausing tests of its driverless car system “Chauffeur”. The decision came even after authorities said Uber was “likely not at fault” for one of its autonomous vehicles striking and killing a pedestrian in Tempe, Ariz., on Sunday. Still, it’s a move one advocacy group exec likely agrees with. “Is getting them out faster the best idea, or is getting them out right the best idea?” Center for Auto Safety executive director Jason Levine told Cheddar before the Toyota news broke. Police investigating the Uber incident claim the car, in self-driving mode with a human behind the wheel, was travelling at 38 mph and made no attempt to brake when a woman walked onto the street. But the pedestrian “came from the shadows right into the roadway,” according to Tempe’s Police Chief, making the accident difficult to avoid in any case. It was the first known fatality caused by a self-driving car, prompting Uber to halt its own pilot programs and raising questions about the future of the nascent technology, with many calling for a slowdown in development. “There should be some step between the computer lab, the completely controlled test track, and releasing them into the communities,” said Levine. The pace of development in this space is moving at a speed that makes it hard to build regulations and safety procedures, he added. “There, right now, are no regulations before putting these things on the road...there’s no pre-investigation or examination of whether the technology meets the same standards as a non-self-driving vehicle.” Autonomous cars have been seen as the futuristic antidote to the tens of thousands of deaths caused by traffic accident deaths every year in the U.S. So far the technology’s track record suggests the error levels are far lower than in traditional autos. The National Transportation Safety Board is currently investigating the Uber incident.

Share:
More In Technology
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Technological Breakthrough in Head Injury Prevention
Dr. Michael Bottlang and Dr. Steve Madey, co-founders of WaveCel, join Cheddar Innovates to share their breakthrough in hard hat design that could have ramifications for protecting against head trauma across industries.
Load More